Test Price
3,500 AED✅ Home Collection Available
Ultra‑Low Input Eukaryotic mRNA Sequencing (Reference‑Based Analysis) in UAE – 3,500 AED – DHA Licensed
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: Paid Hospital‑Grade Home Collection via ISO‑Certified Cold‑Chain Home Collection and VIP Mobile Phlebotomy (Available daily from 8 AM to 11 PM).
- Clinical Guidance: Telephonic Post‑Test Clinical Guidance for result interpretation with a Consultant Medical Genetics.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731 – instant pre‑approval for major UAE networks.
- Full compliance: Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 concerning Health ICT.
Test Overview & Methodology
Ultra‑low input eukaryotic mRNA sequencing is a state‑of‑the‑art transcriptomic assay designed for samples containing as little as 1 picogram of RNA, enabling whole‑transcriptome profiling from precious or scarce specimens such as tumor biopsies, circulating tumor cells, or sorted cell populations.
| Feature | Our Test (Ultra‑Low Input mRNA‑Seq) | Standard RNA‑Seq (High Input) | Microarray Gene Expression |
|---|---|---|---|
| Minimum RNA input | 1 pg – 10 ng | 100 ng – 1 µg | 50 ng – 200 ng |
| Sensitivity for low‑expressed genes | Very high (detection of single transcripts) | High | Moderate (limited to pre‑designed probes) |
| Transcriptome coverage | Whole transcriptome (novel isoforms, splice variants) | Whole transcriptome | Only known targets (~20,000 genes) |
| Turnaround time | 8 weeks | 4 – 6 weeks | 1 – 2 weeks |
| Clinical/Research application | Oncology (rare cell transcriptomics), rheumatology, biomarker discovery | Bulk tumor profiling, tissue studies | Gene expression signature screening |
Physician Insight & Safety Protocols
“As a Consultant Medical Genetics, I emphasize that ultra‑low input mRNA sequencing provides powerful transcriptomic insights, but it must be correlated with the patient’s clinical presentation and other laboratory findings. I urge every patient to review these results with their oncologist or rheumatologist – never act on a single gene expression signature in isolation. Your doctor will integrate this data into a holistic picture of your health.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Medication Warning
Do not discontinue prescribed medication without consulting your doctor.
Exclusion Criteria & Emergency Red Flags
- Exclusion criteria: active systemic infection or recent vaccination within 4 weeks (may skew transcriptome); insufficient RNA yield (<10 pg after extraction); sample collected in non‑validated tubes or from non‑recommended tissue sources.
- This test does not directly trigger medical emergencies. However, if you experience acute chest pain, severe bleeding, sudden neurological deficits, or high‑grade fever, seek urgent care regardless of your test appointment.
This protocol operates in accordance with Federal Decree‑Law No. 4 of 2016 on Medical Liability.
Patient FAQ & Clinical Guidance
1. What exactly does ultra‑low input mRNA sequencing detect?
A: Ultra‑low input mRNA sequencing detects the complete set of messenger RNA transcripts from extremely limited biological samples. This test measures gene expression levels, identifies novel isoforms, and uncovers splice variants even when only picograms of RNA are available, making it ideal for rare cell populations or micro‑dissected tissues.
2. How is the sample collected for this test?
A: Our VIP mobile phlebotomy team collects 5 mL of whole blood in a specialized RNA preservative tube, preserving transcript integrity. At your preferred location, a trained nurse performs venipuncture, immediately stabilizes RNA, and transports the sample in a cold‑chain validated cooler to our ISO‑accredited laboratory within 2 hours.
3. Is insurance coverage available for this advanced transcriptomic test?
A: Insurance preapproval is verified via WhatsApp at +971 54 548 8731; we support direct billing with major UAE networks. We handle all prior authorization paperwork for you. Simply send your insurance card and Emirates ID, and we confirm coverage within one business day; self‑pay customers can also request a detailed compliant invoice.
UAE Regulatory & Data Privacy Adherence
Regulatory Compliance Framework
DNA Labs UAE operates under DHA Facility License 1143. All genomic and transcriptomic data processing strictly adheres to Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent protocols are governed by Federal Decree‑Law No. 4 of 2016 on Medical Liability. Your data is encrypted, anonymized, and stored within secure UAE‑based servers.
Clinical & Logistical Metadata
| Test Name | Ultra‑Low Input Eukaryotic mRNA Sequencing (Reference‑Based Analysis) |
| Price (AED) | 3,500 AED |
| Turnaround Time | 8 weeks |
| Sample Type / Matrix | Whole Blood (Specialized RNA Preservative Tube) or Fresh/Frozen Tissue |
| Methodology Used | Ultra‑low input RNA amplification, SMART‑Seq library preparation, Illumina NGS, GRCh38 reference alignment |
| ICD-10-CM Code | Z13.79, Z14.8, R89.8 |
| LOINC Code | 103164-6 |
| DHA Facility License & Address | License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians